- Home
- FGEN vs GOEV Comparison
FGEN vs GOEV Comparison
Compare FGEN & GOEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- GOEV
- Stock Information
- Founded
- FGEN 1993
- GOEV 2017
- Country
- FGEN United States
- GOEV United States
- Employees
- FGEN N/A
- GOEV N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- GOEV
- Sector
- FGEN Health Care
- GOEV
- Exchange
- FGEN Nasdaq
- GOEV Nasdaq
- Market Cap
- FGEN 34.0M
- GOEV 34.3M
- IPO Year
- FGEN 2014
- GOEV N/A
- Fundamental
- Price
- FGEN $0.36
- GOEV $0.54
- Analyst Decision
- FGEN
- GOEV Strong Buy
- Analyst Count
- FGEN 0
- GOEV 6
- Target Price
- FGEN N/A
- GOEV $23.04
- AVG Volume (30 Days)
- FGEN 1.5M
- GOEV 8.7M
- Earning Date
- FGEN 11-12-2024
- GOEV 11-13-2024
- Dividend Yield
- FGEN N/A
- GOEV N/A
- EPS Growth
- FGEN N/A
- GOEV N/A
- EPS
- FGEN N/A
- GOEV N/A
- Revenue
- FGEN $180,015,000.00
- GOEV $1,864,000.00
- Revenue This Year
- FGEN $20.42
- GOEV $2,999.89
- Revenue Next Year
- FGEN N/A
- GOEV $1,016.40
- P/E Ratio
- FGEN N/A
- GOEV N/A
- Revenue Growth
- FGEN 16.15
- GOEV 259.15
- 52 Week Low
- FGEN $0.18
- GOEV $0.37
- 52 Week High
- FGEN $2.93
- GOEV $8.81
- Technical
- Relative Strength Index (RSI)
- FGEN 50.21
- GOEV 38.26
- Support Level
- FGEN $0.18
- GOEV $0.37
- Resistance Level
- FGEN $0.43
- GOEV $0.76
- Average True Range (ATR)
- FGEN 0.04
- GOEV 0.11
- MACD
- FGEN 0.01
- GOEV 0.01
- Stochastic Oscillator
- FGEN 66.94
- GOEV 32.13
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
About GOEV Canoo Inc.
Canoo Inc is a mobility technology company providing with a proprietary modular electric vehicle platform and connected services initially focused on commercial fleet, government and military customers. The Company has developed a breakthrough EV platform that it believes will enable it to rapidly iterate and bring new products, addressing multiple use cases, to market faster than competition and at lower cost.